FDA commissioner Dr. Marty Makary on vaccine safety and recommendations

Public Trust & Vaccine Sentiment - The COVID-19 pandemic led to a significant decline in public trust in doctors and hospitals, dropping from 71% to 40%, a 31 percentage point decrease [4] - Vaccine mandates for young, healthy individuals may have contributed to a rise in anti-vaccine sentiment and a loss of public trust [4] - Ignoring natural immunity was a factor in the loss of public trust [5] - The industry is trying to rebuild public trust through radical transparency and emphasizing the importance of individual doctor-patient relationships [6] Vaccine Recommendations & Policy - Concerns exist regarding the composition of the vaccine advisory committee at the CDC [7] - The previous committee's push for COVID-19 boosters in young, healthy people may have led to a backlash [8] - There was limited evidence supporting repeat boosters in young, healthy children, and a myocarditis risk was downplayed in young males [8] - An evidence-based, risk-stratified approach to vaccine recommendations is advocated, considering high-risk versus low-risk individuals [10] - The FDA's role is to determine the safety and effectiveness of submitted applications [14] - Concerns were raised about a policy of rubber-stamping COVID-19 vaccines for young, healthy individuals without clinical trials [15]